0001209191-16-119110.txt : 20160511
0001209191-16-119110.hdr.sgml : 20160511
20160511161118
ACCESSION NUMBER: 0001209191-16-119110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160509
FILED AS OF DATE: 20160511
DATE AS OF CHANGE: 20160511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161640005
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-05-09
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2016-05-09
4
S
0
800
86.69
D
15950
D
Common Stock
2016-05-09
4
S
0
1100
87.49
D
14850
D
Common Stock
2016-05-09
4
S
0
1100
88.44
D
13750
D
Common Stock
169
I
401k
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $86.69 (range $85.99 to $86.98).
Open market sales reported on this line occurred at a weighted average price of $87.49 (range $86.99 to $87.94).
Open market sales reported on this line occurred at a weighted average price of $88.44 (range $88.00 to $88.68).
Omar White, Attorney-In-Fact
2016-05-11